Non-Small Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Non-Small Cell Lung Cancer-Global API Manufacturers, Marketed and P
(EMAILWIRE.COM, September 23, 2017 ) “Non-Small Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Non-Small Cell Lung Cancer. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Non-Small Cell Lung Cancer which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.
Secondary information and data has been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations and available databases.
Scope
A review of the marketed products for Non-Small Cell Lung Cancer including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2020 and API manufacturer details.
Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details
API manufacturers for the marketed products with location details
Emerging Phase III product profiles for Non-Small Cell Lung Cancer including product description, developmental activities, licensors & collaborators and chemical information
Get a PDF Sample of Report at: http://www.orbisresearch.com/contacts/request-sample/232268 .
Reasons to Buy
API intelligence for marketed drugs for the indication and gaining insights of API manufacturers
Evaluate the marketing status and patent details of products to exploit opportunities for generic drug development
Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to the indication
Establish a comprehensive understanding of the emerging Phase III products which can be future competitors in this space
No. of Report Pages: 60
Place a Purchase Order for this Market Report at: http://www.orbisresearch.com/contact/purchase/232268 .
List Of Tables:
Table 1: List of Marketed and Emerging Products
Table 2: Drug Annual Global Sales from 2011-2016 (in million USD)
Table 3: Drug Annual Global Sales from 2017-2020 (in million USD)
Table 4: Active Pharmaceutical Manufacturers by Country
Table 5: Active Pharmaceutical Manufacturers by Region
Figure 1: Comparative Analysis of Marketed and Emerging Products
Figure 2: Drug Annual Global Sales from 2011-2016 (in million USD)
Figure 3: Drug Annual Global Sales from 2017-2020 (in million USD)
Figure 4: Active Pharmaceutical Manufacturers by Country
Figure 5: Active Pharmaceutical Manufacturers by Region
Got any Query? Feel free to ask us at : http://www.orbisresearch.com/contacts/enquiry-before-buying/232268 .
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.
Secondary information and data has been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations and available databases.
Scope
A review of the marketed products for Non-Small Cell Lung Cancer including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2020 and API manufacturer details.
Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details
API manufacturers for the marketed products with location details
Emerging Phase III product profiles for Non-Small Cell Lung Cancer including product description, developmental activities, licensors & collaborators and chemical information
Get a PDF Sample of Report at: http://www.orbisresearch.com/contacts/request-sample/232268 .
Reasons to Buy
API intelligence for marketed drugs for the indication and gaining insights of API manufacturers
Evaluate the marketing status and patent details of products to exploit opportunities for generic drug development
Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to the indication
Establish a comprehensive understanding of the emerging Phase III products which can be future competitors in this space
No. of Report Pages: 60
Place a Purchase Order for this Market Report at: http://www.orbisresearch.com/contact/purchase/232268 .
List Of Tables:
Table 1: List of Marketed and Emerging Products
Table 2: Drug Annual Global Sales from 2011-2016 (in million USD)
Table 3: Drug Annual Global Sales from 2017-2020 (in million USD)
Table 4: Active Pharmaceutical Manufacturers by Country
Table 5: Active Pharmaceutical Manufacturers by Region
Figure 1: Comparative Analysis of Marketed and Emerging Products
Figure 2: Drug Annual Global Sales from 2011-2016 (in million USD)
Figure 3: Drug Annual Global Sales from 2017-2020 (in million USD)
Figure 4: Active Pharmaceutical Manufacturers by Country
Figure 5: Active Pharmaceutical Manufacturers by Region
Got any Query? Feel free to ask us at : http://www.orbisresearch.com/contacts/enquiry-before-buying/232268 .
Contact Information:
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results